BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
7,6400
13-ноября-24 15:45:00
15 мин. задержка
Акции
-0,1800
-2,30%
Сегодняшний диапазон
7,6300 - 8,0000
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 фев 2023 06:00:30 Источник Nasdaq GlobeNewswire
-
03 фев 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
26 янв 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
23 янв 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
09 янв 2023 06:05:55 Источник Nasdaq GlobeNewswire
-
09 янв 2023 06:00:40 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 янв 2023 06:00:28 Источник Nasdaq GlobeNewswire
-
BioCryst to Present at 41st Annual J.P. Morgan Healthcare Conference
04 янв 2023 06:00:46 Источник Nasdaq GlobeNewswire
-
15 дек 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 дек 2022 15:01:09 Источник Nasdaq GlobeNewswire
-
BioCryst to Present at JMP Securities Hematology & Oncology Summit
05 дек 2022 06:00:26 Источник Nasdaq GlobeNewswire
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Israeli Ministry of Health
28 ноя 2022 06:00:43 Источник Nasdaq GlobeNewswire
-
10 ноя 2022 07:00:21 Источник Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
09 ноя 2022 06:00:33 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 ноя 2022 06:00:46 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Third Quarter 2022 Financial Results and Upcoming Key Milestones
01 ноя 2022 06:00:35 Источник Nasdaq GlobeNewswire
-
24 окт 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
BioCryst to Report Third Quarter 2022 Financial Results on November 1
18 окт 2022 06:00:39 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 окт 2022 06:00:45 Источник Nasdaq GlobeNewswire
-
14 сен 2022 15:01:10 Источник Nasdaq GlobeNewswire